Dr. David Weinstock is a hematologist/oncologist with expertise in hematopoietic stem cell transplantation (HSCT) and has published extensively on clinical complications among transplant recipients. Between 2008-2022, he led a laboratory focused on the intersection between aberrant DNA repair and lymphoid transformation. In 2022, he joined Merck Research Laboratory as Vice President of Discovery Oncology.